FATE insider trading
See Fate Therapeutics (FATE) insider purchases and sales from SEC Form 4, with trade dates, shares, prices, values and links to the filings.
Insider trades
| Insider | Role | Trade | Traded | Filed | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|
| Adawi Kamal | Chief Financial Officer | Sell | Nov 3, 2026 | Nov 4, 2026 | 6,582 | $2.05 | $13.52K | Filing |
| TAHL CINDY | See Remarks | Sell | Aug 4, 2026 | Aug 5, 2026 | 38,800 | $2.46 | $95.45K | Filing |
| Valamehr Bahram | President and CEO, Director | Sell | Aug 4, 2026 | Aug 5, 2026 | 43,947 | $2.46 | $108.11K | Filing |
| TAHL CINDY | See Remarks | Sell | May 20, 2026 | May 21, 2026 | 25,590 | $1.88 | $48.08K | Filing |
| Valamehr Bahram | President and CEO, Director | Sell | May 20, 2026 | May 21, 2026 | 28,946 | $1.88 | $54.48K | Filing |
| TAHL CINDY | See Remarks | Sell | Jan 9, 2026 | Jan 12, 2026 | 10,589 | $1.06 | $11.28K | Filing |
| Valamehr Bahram | President and CEO, Director | Sell | Jan 9, 2026 | Jan 12, 2026 | 5,190 | $1.07 | $5.56K | Filing |
| TAHL CINDY | See Remarks | Sell | Aug 4, 2025 | Aug 5, 2025 | 9,037 | $1.06 | $9.57K | Filing |
| Valamehr Bahram | President and CEO, Director | Sell | Aug 4, 2025 | Aug 5, 2025 | 14,466 | $1.06 | $15.40K | Filing |
| Bressi Jerome Charles | See Remarks | Sell | Jan 10, 2025 | Jan 13, 2025 | 5,980 | $1.55 | $9.27K | Filing |
| TAHL CINDY | See Remarks | Sell | Jan 10, 2025 | Jan 13, 2025 | 5,654 | $1.55 | $8.76K | Filing |
| Valamehr Bahram | President and CEO, Director | Sell | Jan 10, 2025 | Jan 13, 2025 | 8,705 | $1.54 | $13.41K | Filing |
| Redmile Group, LLC | Director, 10% owner | Sell | Dec 20, 2024 | Dec 26, 2024 | 341,633 | $1.68 | $573.94K | Filing |
| Redmile Group, LLC | Director, 10% owner | Buy | Dec 20, 2024 | Dec 26, 2024 | 397,964 | $1.68 | $668.58K | Filing |